Myometrial invasion by endometrial carcinoma: Evaluation with 3.0T MR imaging

Abdominal Imaging

Volumn 36, Issue 5, 2011, Pages 612-618

  Kaneda, Sachi ^a   Fujii, Shinya ^a   Fukunaga, Takeru ^a   Kakite, Suguru ^a   Kaminou, Toshio ^a   Kigawa, Junzo ^a   Harada, Tasuku ^a   Ogawa, Toshihide ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Endometrial neoplasms; High field strength imaging; Magnetic resonance imaging; Pelvis; Uterus

Indexed keywords

CONTRAST MEDIUM; GADOTERATE DIMEGLUMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CURETTAGE; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LEIOMYOMA; LYMPHADENECTOMY; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY; CONTRAST MEDIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 83155175456     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9719-8     Document Type: Article

References (45)

1. Hamlin DJ, Burgener FA, Beecham JB (1981) CT of intramural endometrial carcinoma: contrast enhancement is essential. AJR Am J Roentgenol 137:551-554 (Pubitemid 11040159)
2. Walsh JW, Goplerud DR (1982) Computed tomography of primary, persistent, and recurrent endometrial malignancy. AJR Am J Roentgenol 139:1149-1154 (Pubitemid 13201967)
3. Balfe DM, Van Dyke J, Lee JK, Weyman PJ, McClennan BL (1983) Computed tomography in malignant endometrial neoplasms. J Comput Assist Tomogr 7:677-681 (Pubitemid 13035955)
4. Hardesty LA, SumKin JH, Nath ME, et al. (2000) Use of preoperative MR imaging in the management of endometrial carcinoma: cost analysis. Radiology 215:45-49 (Pubitemid 30190509)
5. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N (1991) MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179:829-832
6. Sironi S, Taccagni G, Garancini P, Belloni C, DelMaschio A (1992) Myometrial invasion by endometrial carcinoma: assessment by MR imaging. AJR Am J Roentgenol 158:565-569
7. Sironi S, Colombo E, Villa G, et al. (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185:207-212
8. Takahashi S, Murakami T, Narumi Y, et al. (1998) Preoperative staging of endometrial carcinoma: diagnostic effect of T2-weighted fast spin-echo MR imaging. Radiology 206:539-547 (Pubitemid 28112972)
9. Kinkel K, Kaji Y, Yu KK, et al. (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711-718 (Pubitemid 29410973)
10. Frei KA, Kinkel K, Bonel HM, et al. (2000) Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging - a meta analysis and Bayesian analysis. Radiology 216:444-449 (Pubitemid 30599864)
11. Joja I, Asakawa M, Asakawa T, et al. (1996) Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 20:878-887 (Pubitemid 26392549)
12. Saez F, Urresola A, Larena JA, et al. (2000) Endometrial carcinoma: assessment of myometrial invasion with plain and gadolinium- enhanced MR imaging. J Magn Reson Imaging 12:460-466
13. Savci G, Ozyaman T, Tutar M, et al. (1998) Assessment of depth of myometrial invasion by endometrial carcinoma: comparison of T2- weighted SE and contrast-enhanced dynamic GRE MR imaging. Eur Radiol 8:218-223 (Pubitemid 128546204)
14. Seki H, Kimura M, Sakai K (1997) Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrastenhanced T1-weighted images. Clin Radiol 52:18-23
15. Edelman RR, Salanitri G, Brand R, et al. (2006) Magnetic resonance imaging of the pancreas at 3.0 Tesla: qualitative and quantitative comparison with 1.5 Tesla. Invest Radiol 41:175-180 (Pubitemid 44406215)
16. Morakkabati-Spitz N, Gieseke J, Kuhl C, et al. (2005) 3.0T highfield magnetic resonance imaging of the female pelvis: preliminary experiences. Eur Radiol 15:639-644
17. Merkle EM, Dale BM (2006) Abdominal MRI at 3.0T: the basics revisited. AJR Am J Roentgenol 186:1524-1532 (Pubitemid 46112514)
18. Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946-959 (Pubitemid 41166727)
19. Tanenbaum LN (2006) Clinical 3T MR imaging: mastering the challenges. Magn Reson Imaging Clin N Am 14:1-15 (Pubitemid 43363394)
20. Hori M, Kim T, Murakami T, et al. (2009) MR imaging of endometrial carcinoma for preoperative staging at 3.0T: comparison with imaging at 1.5T. J Magn Reson Imaging 30:621-630
21. Kuhl CK, Träber F, Schild HH (2008) Whole-body high-fieldstrength (3.0 T) MR imaging in clinical practice. Part I. Technical considerations and clinical applications. Radiology 246:675-696
22. Torricelli P, Ferraresi S, Fiocchi F, et al. (2008) 3T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR Am J Roentgenol 190:489-495 (Pubitemid 351196622)
23. Sreenivas M, Lowry M, Gibbs P, Pickles M, Turnbull LW (2007) Asimple solution for reducing artifacts due to conductive and dielectric effects in clinical magnetic resonance imaging at 3T. Eur J Radiol 62:143-146 (Pubitemid 46413622)
24. Kataoka M, Isoda H, Maetani Y, et al. (2007) MR imaging of the female pelvis at 3 Tesla: evaluation of image homogeneity using different dielectric pads. J Magn Reson Imaging 26:1572-1577 (Pubitemid 350291286)
25. Hori M, Kim T, Murakami T, et al. (2009) Uterine cervical carcinoma: preoperative staging with 3.0T MR imaging-comparison with 1.5T MR imaging. Radiology 251:96-104
26. Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850-855 (Pubitemid 32479941)
27. Yamashita Y, Harada M, Sawada T, et al. (1993) Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadoliniumenhanced MR imaging. Radiology 186:459-501
28. Lee EJ, Byun JY, Kim BS, Koong SE, Shinn KS (1999) Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. Radiographics 19:937-945
29. Nakao Y, Yokoyama M, Hara K, et al. (2007) MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 102:343-347
30. Hahn HS, Yoon SG, Hong JS, et al. (2009) Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 19:1068-1073
31. Hricak H, Stern JL, Fisher MR, et al. (1987) Endometrial carcinoma staging by MR imaging. Radiology 162:297-305 (Pubitemid 17015626)
32. Scoutt LM, McCarthy SM, Flynn SD, et al. (1995) Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress. Radiology 194:567-572
33. Sala E, Crawford R, Senior E, et al. (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19:141-146
34. Kataoka M, Kido A, Koyama T, et al. (2007) MRI of the female pelvis at 3T compared to 1.5T: evaluation on high-resolution T2- weighted and HASTE images. J Magn Reson Imaging 25:527-534 (Pubitemid 46355414)
35. Ascher SM, Reinhold C (2002) Imaging of cancer of the endometrium. Radiol Clin North AM 40:563-576 (Pubitemid 34765040)
36. Chung HH, Kang SB, Cho JY, et al. (2007) Accuracy of MRI for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol 104:654-659 (Pubitemid 46240257)
37. Nöbauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, et al. (2002) Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla. Invest Radiol 37:114-119 (Pubitemid 34225507)
38. Kuhl CK, Jost P, Morakkabati N, et al. (2006) Contrast-enhanced MR imaging of the breast at 3.0 and 1.5T in the same patients: initial experience. Radiology 239:666-676 (Pubitemid 43830601)
39. Berman ML, Ballon SC, Lagasse LD, Watring WG (1980) Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 136:679-688 (Pubitemid 10156234)
40. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA (1985) Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 151:1009-1015 (Pubitemid 15039768)
41. Cowles TA, Magrina JF, Masterson BJ, Capen CV (1985) Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol 66:413-416 (Pubitemid 15016586)
42. Boronow RC, Morrow CP, Creasman WT, et al. (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825-832 (Pubitemid 14105231)
43. Creasman WT, Morrow CP, Bundy BN, et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035-2041 (Pubitemid 17145924)
44. Manfredi R, Mirk P, Maresca G, et al. (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372-378 (Pubitemid 38552891)
45. Barwick TD, Rockall AG, Borton DP, Sohaib SA (2006) Imaging of endometrial adenocarcinoma. Clin Radiol 61:545-555 (Pubitemid 43899341)